Ryan Bartolucci is Vice President - Finance, Corporate Controller of the Company. He joined RTI Surgical in September 2018 as Vice President, Finance and Corporate Controller. Prior to joining the Company, Mr. Bartolucci, was employed with Sagent Pharmaceuticals, a generic injectable company, from August 2015 to September 2018. Mr. Bartolucci started his career at PricewaterhouseCoopers LLP, where, during his eleven years at the firm, he served in various assurance roles. A certified public accountant, Mr. Bartolucci joins as a proven leader of talented accounting professionals, with strong acumen in technical accounting, financial reporting and compliance and controls.
Ryan Bartolucci is 37, he's been the Vice President - Finance e Corporate Controller of RTI Surgical since 2018. There are 10 older and no younger executives at RTI Surgical. The oldest executive at RTI Surgical Holdings, Inc. is Thomas McEachin, 67, who is the Independent Director.
Ryan's mailing address filed with the SEC is 520 LAKE COOK ROAD, SUITE 315, DEERFIELD, IL, 60015.
Over the last 21 years, insiders at RTI Surgical have traded over $71,830 worth of RTI Surgical stock and bought 390,515 units worth $1,973,594 . The most active insiders traders include Jeffrey C Lightcap, Mark Stolper, eTerry M. Rich. On average, RTI Surgical executives and independent directors trade stock every 138 days with the average trade being worth of $62,561. The most recent stock trade was executed by Jonathon M Singer on 12 December 2018, trading 50,000 units of RTIX stock currently worth $214,000.
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
RTI Surgical executives and other stock owners filed with the SEC include: